History of stroke and coronary heart disease—a fatal combination

History of stroke and coronary heart disease -- a fatal combination
Credit: Serimedis/Inserm

(Medical Xpress)—Heart and cerebro-vascular disorders represent the two leading causes of death throughout the world. They are sometimes combined in a single patient and their combination represents both a considerable risk to the patient and a therapeutic challenge.

Today's anti-thromobotic, blood-thinning medication provides effective treatment for . Several randomised tests to assess new anti-thrombotic treatments in have identified the fact that a history of stroke or TIA constitutes a marker for increased risk of intracranial bleeding that could prove fatal for the patient. The study was conducted by the Cardiology Service Team of the Bichat Hospital and INSERM Unit 698, working with several international teams, and consisted in monitoring and analysing 26,389 coronary patients from REACH, the international register of athero-thrombic patients, over a four-year period, in order to very accurately assess the ischaemic and haemorrhagic risk associated with a history of stroke or TIA in coronary patients.

The results of this study highlight the frequency of the phenomenon. It showed that 4,460 patients, 17% of the cohort of coronary patients, had a history of stroke or TIA. This stroke or TIA antecedent was associated, moreover, with an approximate 50% increase (in relation to coronary patients without a history of stroke) of dying from a or stroke, with increased risk of ischæmic and hæmorrhagic stroke.

This study also aims at investigating the therapeutic challenge of treating such patients. In fact, higher doses of anti- or anti-coagulant are associated with a particularly high increased risk of hæmorrhage.

"The conclusions of the study are important since they emphasise the difficulty in treating this type of patient, a type that is frequent but whose prognosis is particularly serious. It also shows how important it is to provide the right anti-thrombotic treatment. Additional clinical trials are currently being conducted to test new treatment strategies for these patients", explained Professor Steg of the Cardiology Department at the Hôpital Bichat.

add to favorites email to friend print save as pdf

Related Stories

Mini-stroke doubles risk of heart attack

Mar 24, 2011

Patients who have suffered a "mini stroke" are at twice the risk of heart attack than the general population, according to research reported in Stroke: Journal of the American Heart Association.

TARDIS trial seeks new dimension in stroke treatment

Oct 17, 2011

People who suffer from acute stroke or Transient Ischaemic Attack (TIA, a mini stroke) could get better treatment in the future thanks to the expansion of a large clinical trial of a new combination of drugs led by researchers ...

Review of stroke treatment could save lives

Sep 30, 2011

Doctors are underutilising crucial medication to prevent deadly strokes in those with a common type of heart condition, new research says, leading to fresh calls for a review of current treatment strategies and more research ...

Recommended for you

Researchers explain 38-year-old mystery of the heart

15 hours ago

In a new study published in Proceedings of the National Academy of Sciences, researchers at the University of Alberta's Faculty of Medicine & Dentistry have explained how the function of a key protein in the ...

User comments